Calheiros-Lobo, M.; Silva, J.P.N.; Pinto, B.; Monteiro, L.; Silva, P.M.A.; Bousbaa, H.
Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer. Pharmaceutics 2024, 16, 1196.
https://doi.org/10.3390/pharmaceutics16091196
AMA Style
Calheiros-Lobo M, Silva JPN, Pinto B, Monteiro L, Silva PMA, Bousbaa H.
Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer. Pharmaceutics. 2024; 16(9):1196.
https://doi.org/10.3390/pharmaceutics16091196
Chicago/Turabian Style
Calheiros-Lobo, Mafalda, João P. N. Silva, Bárbara Pinto, LuÃs Monteiro, PatrÃcia M. A. Silva, and Hassan Bousbaa.
2024. "Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer" Pharmaceutics 16, no. 9: 1196.
https://doi.org/10.3390/pharmaceutics16091196
APA Style
Calheiros-Lobo, M., Silva, J. P. N., Pinto, B., Monteiro, L., Silva, P. M. A., & Bousbaa, H.
(2024). Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer. Pharmaceutics, 16(9), 1196.
https://doi.org/10.3390/pharmaceutics16091196
